Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $444M; returns 1 day -4.8%, 1 week -2.8%, 1 year +15.4%.

Tectonic Therapeutic, Inc. (TECX), headquartered in Watertown, Massachusetts, is a biotechnology company focused on discovering and developing therapeutic proteins and antibodies, particularly targeting G protein-coupled receptors (GPCRs). The company utilizes its GEODe technology platform to develop GPCR-targeted biologic medicines.

Groups TECX belongs to

• GPCR Targeting
• Biotechnology
• Biopharmaceutical
• Life Sciences
• Clinical Stage Biotech
• Clinical Stage
• Biologics
• Healthcare
• Drug Discovery
• Antibody Therapeutics

TECX financial model: income statement, cash flow and balance sheet